摘要
目的 探讨辛伐他汀联合戈舍瑞林及腹腔镜治疗子宫内膜异位症(endometriosis, EMs)对卵巢储备功能及血清抗子宫内膜抗体(endometrial antibody, EMAb)、纤溶酶原激活物抑制剂-1(plasminogen activator inhibitor-1,PAI-1)、单核细胞趋化蛋白-1(monocyte chemotactic protein-1,MCP-1)的影响。方法 选取2020年4月至2022年5月平顶山市第一人民医院诊治的82例EMs患者作为研究对象,分为两组,每组各41例。结果 观察组治疗后总有效率、VE、SOD、1年妊娠率高于对照组,而E_(2)、FSH、LH、EMAb、PAI-1、MCP-1、ROS和复发率低于对照组(P<0.05)。结论 辛伐他汀联合戈舍瑞林及腹腔镜治疗EMs具有较为理想效果,有利于改善卵巢功能和降低EMAb、PAI-1、MCP-1表达。
Objective To investigate the effects of simvastatin combined with goserrelin and laparoscopy on ovarian reserve function,endometriosis antibody(EMAb),plasminogen activator inhibitor-1(PAI-1)and monocyte chemotactic protein-1(MCP-1)in endometriosis(EMs).Methods A total of 82 EMs patients diagnosed and treated from April 2020 to May 2022 were selected as the study objects and divided into 2 groups,with 41 patients in each group.ResultsAfter treatment,the total effective rate,VE,SOD and 1-year pregnancy rate in observation group were higher than those in control group,while E_(2),FSH,LH,EMAb,PAI-1,MCP-1,ROS and recurrence rate were lower than those in control group(P<0.05).Conclusionn Simvastatin combined with goserelin and laparoscopic treatment of EMs has a better effect,which is beneficial to improve ovarian function and reduce EMAb,PAI-1,MCP-1 expression.
作者
黄娟
王静
李伦
HUANG Juan;WANG Jing;LI Lun(Department of Obstetrics and Gynecology,the First Peoples Hospital of Pingdingshan City,Pingdingshan,Henan 467000,China;Department of Clinical Laboratory,the First Peoples Hospital of Pingdingshan City,Pingdingshan,Henan 467000,China)
出处
《医药论坛杂志》
2024年第17期1877-1880,共4页
Journal of Medical Forum